Table 1.
Classic PTC | FVPTC | Total | |
---|---|---|---|
Sex (n) | |||
Female | 18 | 10 | 28 |
Male | 9 | 7 | 16 |
Age (years) | |||
Years±SE Mean | 47.8±3 | 50.9±4.3 | 49±3 |
pT | |||
pT1 | 4 | 1 | 5 |
pT2 | 3 | 0 | 3 |
pT3 | 20 | 15 | 35 |
pT4 | 0 | 1 | 1 |
Status OS (n) | |||
Censored | 24 | 13 | 37 |
Death | 3 | 4 | 7 |
t follow-up OS (months) | 74.6±47 | 80.8±47.4 | 77±46.7 |
Status TSS (n) | |||
Censored | 25 | 16 | 41 |
Death | 2 | 1 | 3 |
t follow-up TSS (months) | 74.6±47 | 80.8±47.4 | 77±46.7 |
Status relapse (n) | |||
Censored | 8 | 8 | 16 |
Relapse | 19 | 9 | 28 |
t follow-up RFS (months) | 25.7±29.6 | 55.9±54 | 37.4±42.8 |
Total (n) | 27 | 17 | 44 |
PTC, papillary thyroid carcinoma; FVPTC, follicular variant of papillary thyroid carcinoma; OS, overall survival; TSS, tumor-specific survival; RFS, relapse-free survival.